Format

Send to

Choose Destination
Cell Stem Cell. 2013 Jun 6;12(6):644-7. doi: 10.1016/j.stem.2013.05.017.

Cell therapy companies make strong progress from October 2012 to March 2013 amid mixed stock market sentiment.

Author information

1
Advanced Centre for Biochemical Engineering, University College London, Gower Street, London, WC1E 6BT, UK. chris.mason@ucl.ac.uk

Abstract

During Q4 2012 and Q1 2013, the cell therapy industry made strong progress in translation and commercialization. Continued development of the companies included in a dedicated stock market index suggests emergence of this industry as a distinct healthcare sector.

PMID:
23746973
DOI:
10.1016/j.stem.2013.05.017
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center